David McKinley actually said...

So we know the loser here is going to be the American public if we don't get a bill to the President's desk for signature.

But pursuing this highly partisan H.R. 3 is just an example of overreach, unfortunate overreach, that occurs too often in Washington, and it...

If I could, I want to ask a last question to Dr. Gupta because the United States, we are still--across the country still experiencing a wave...

We need a robust biopharma industry, and I think everyone agrees to that, investing in rare diseases.